← All trials
NCT02922075
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 1, 2013
- Primary completion
- Dec 1, 2013
- Completion date
- Jun 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 24
- Arms / groups
- 3 / —
- Source
- AACT · pre-existing
Sponsors
- Sao Paulo State UniversityLead sponsor
- Fundação de Amparo à Pesquisa do Estado de São PauloCollaborator
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.